Filter posts

Gates Foundation Issues Biotech Call to Action

Today, Trevor Mundel from the Bill & Melinda Gates Foundation discussed the untapped potential of …

Patent Parameters

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court …

Reimbursement Considerations for Early Stage Companies

Panelists at Tuesday’s breakout session – Reimbursement Considerations for Early Stage Companies – overwhelmingly agreed …

Integrate and Collaborate to Drive Advancements in Oncology Treatments

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, …

Turning the Tide on STEM Education

According to the US Department of Education, only 16 percent of American high school seniors …

Syringes for Clinical Trials

Today’s pharmaceutical and biotechnology companies are under pressure to remain competitive. To do so, they …